Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
-
Brunswick Exploration Drills 93.45 Meters at 1.55% Li2O at MR-6
-
Standard Uranium Begins Inaugural Drill Program at Canary Project, Eastern Athabasca Basin
-
Microbix Schedules Release of Results for Q2 Fiscal 2024
-
Hain Celestial Reports Fiscal Third Quarter 2024 Financial Results
-
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
-
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
-
Genius Sports Reports First Quarter Results Above Expectations and Raises 2024 Group Revenue and Adj. EBITDA Guidance
-
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
-
ENTRÉE RESOURCES ANNOUNCES FIRST QUARTER 2024 RESULTS
-
Valvoline Inc. Reports Second Quarter Results
-
Canadian Solar Secures 193 MW of BESS Projects in Japan's Inaugural Long-term Decarbonization Power Source Auction
-
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
-
TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR
-
New Fortress Energy Announces First Quarter 2024 Results
-
RumbleOn Reports First Quarter 2024 Financial Results
-
Qurate Retail, Inc. Reports First Quarter 2024 Financial Results
-
EREZ ASSET MANAGEMENT SENDS LETTER TO WHITESTONE SHAREHOLDERS QUESTIONING RECENT CONDUCT OF WHITESTONE REIT BOARD
-
R1 RCM Reports First Quarter 2024 Results
-
WELL Health Reports Record Quarterly Revenue and Record Net Income for a first quarter in Q1-2024 and Increases Both Revenue and Adjusted EBITDA Guidance for 2024
-
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
-
Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma
-
Caesarstone Reports First Quarter 2024 Financial Results
-
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
Affirm Reports Third Fiscal Quarter 2024 Results
-
Opera to Participate in Upcoming Investor Conferences
-
Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
-
Sunoco LP Announces First Quarter 2024 Financial and Operating Results
-
Dragonfly Energy Named Business of the Year at Nevada Business Awards
-
Dine Brands Global, Inc. Reports First Quarter 2024 Results
-
Gemoo Launched CapUp to Make Viral Videos for Tiktok, Instagram, and YouTube easily and Instantly
-
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS AND REFINED INTERPRETATIONS AT LA LUISA
-
Pixelgen Technologies Announces Peer-Review Publication on Molecular Pixelation Technology in Nature Methods
-
Silver Lake Closes $20.5 Billion Fundraise for SLP VII
-
Starwood Property Trust Reports Results for Quarter Ended March 31, 2024
-
Fast Guard Service Reveals the True Costs of Emergency Security Guard Services in a Comprehensive Industry Guide
-
Performance Food Group Company Reports Third-Quarter and First-Nine Months Fiscal 2024 Results
-
Softchoice Announces First Quarter 2024 Results
-
Sage launches two new integrated suites in Canada and the UK to help Accountants and Small Businesses drive growth
-
Vistra Reports First Quarter 2024 Results, Raises Expectations for Energy Harbor and Consolidated Adjusted EBITDA
-
TrustRadius Announces 2024 Top Rated Award Winners
-
ReposiTrak Adds 20 New Seafood Suppliers to the Queue for the Rapidly Expanding Food Traceability Network
-
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Alteryx, Inc. Announces Extension of Change of Control Offer
-
Broadridge Reports Third Quarter Fiscal 2024 Results
-
Arbor Biotechnologies Announces Acquisition of Serendipity
-
TEGNA and Indiana Fever Expand Broadcast Distribution of the Fever’s Exciting Upcoming Season in 11 Additional Markets
-
Innoviva to Participate in the BofA Securities Health Care Conference
-
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024


